fda tobacco products scientific advisory committee Rutgers Professor Appointed to FDA's PMI urges FDA to authorize
PMI urges FDA to authorize Zyn as a modified risk tobacco product FDA knew stop smoking product clinical trials not science based October 7, 2025: Tobacco Products Scientific Advisory Committee Meeting Today, the FDA is holding an advisory committee meeting to discuss Zyn's application to market its nicotine pouches with a modified risk claim. This modified risk concept, often referred to as harm
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


